Log in

NASDAQ:OMCL - Omnicell Stock Price, Forecast & News

$81.52
+1.16 (+1.44 %)
(As of 12/8/2019 07:42 AM ET)
Today's Range
$80.04
Now: $81.52
$81.79
50-Day Range
$69.40
MA: $75.74
$81.89
52-Week Range
$56.96
Now: $81.52
$92.59
Volume194,094 shs
Average Volume222,691 shs
Market Capitalization$3.42 billion
P/E Ratio53.28
Dividend YieldN/A
Beta1.12
Omnicell, Inc provides medication and supply dispensing automation, central pharmacy automation, analytics software, and medication adherence solutions for the healthcare industry worldwide. It operates in two segments, Automation and Analytics, and Medication Adherence. The Automation and Analytics segment offers central pharmacy automation solutions, including automated storage and retrieval systems, such as XR2 Automated Central Pharmacy System, a building block of autonomous pharmacy vision; IV compounding robots and workflow management systems; inventory management software; and controlled substance management systems. Read More…

Industry, Sector and Symbol

Industry Electronic computers
Sub-IndustryHealth Care Technology
SectorMedical
Current SymbolNASDAQ:OMCL
CUSIP68213N10
Phone650-251-6100

Debt

Price-To-Earnings

Sales & Book Value

Annual Sales$787.31 million
Cash Flow$2.95 per share
Book Value$17.15 per share

Profitability

Net Income$37.73 million

Miscellaneous

Employees2,480
Market Cap$3.42 billion
Next Earnings Date2/6/2020 (Estimated)
OptionableOptionable

Receive OMCL News and Ratings via Email

Sign-up to receive the latest news and ratings for OMCL and its competitors with MarketBeat's FREE daily newsletter.


Omnicell (NASDAQ:OMCL) Frequently Asked Questions

What is Omnicell's stock symbol?

Omnicell trades on the NASDAQ under the ticker symbol "OMCL."

How were Omnicell's earnings last quarter?

Omnicell, Inc. (NASDAQ:OMCL) released its quarterly earnings data on Thursday, October, 24th. The company reported $0.76 EPS for the quarter, beating the Zacks' consensus estimate of $0.71 by $0.05. The company earned $228.80 million during the quarter, compared to the consensus estimate of $231.86 million. Omnicell had a net margin of 6.28% and a return on equity of 11.90%. Omnicell's quarterly revenue was up 12.0% on a year-over-year basis. During the same quarter in the prior year, the firm earned $0.63 EPS. View Omnicell's Earnings History.

When is Omnicell's next earnings date?

Omnicell is scheduled to release their next quarterly earnings announcement on Thursday, February 6th 2020. View Earnings Estimates for Omnicell.

What guidance has Omnicell issued on next quarter's earnings?

Omnicell issued an update on its fourth quarter earnings guidance on Thursday, October, 24th. The company provided EPS guidance of $0.75-0.80 for the period, compared to the Thomson Reuters consensus estimate of $0.79. The company issued revenue guidance of $240-246 million, compared to the consensus revenue estimate of $243.20 million.

What price target have analysts set for OMCL?

5 analysts have issued 12 month price targets for Omnicell's shares. Their forecasts range from $70.00 to $92.00. On average, they expect Omnicell's stock price to reach $83.80 in the next twelve months. This suggests a possible upside of 2.8% from the stock's current price. View Analyst Price Targets for Omnicell.

What is the consensus analysts' recommendation for Omnicell?

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Omnicell in the last year. There are currently 2 hold ratings and 3 buy ratings for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for Omnicell.

Has Omnicell been receiving favorable news coverage?

Press coverage about OMCL stock has been trending somewhat positive this week, according to InfoTrie Sentiment Analysis. The research firm scores the sentiment of press coverage by monitoring more than six thousand blog and news sources in real-time. The firm ranks coverage of public companies on a scale of negative five to positive five, with scores nearest to five being the most favorable. Omnicell earned a coverage optimism score of 1.0 on InfoTrie's scale. They also gave media headlines about the company a news buzz of 0.0 out of 10, indicating that recent press coverage is extremely unlikely to have an effect on the company's share price in the next several days. View News Stories for Omnicell.

Who are some of Omnicell's key competitors?

What other stocks do shareholders of Omnicell own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Omnicell investors own include AT&T (T), Adobe (ADBE), Micron Technology (MU), AbbVie (ABBV), Bank of America (BAC), Johnson & Johnson (JNJ), Netflix (NFLX), NVIDIA (NVDA), Paypal (PYPL) and QUALCOMM (QCOM).

Who are Omnicell's key executives?

Omnicell's management team includes the folowing people:
  • Mr. Randall A. Lipps, Founder, Exec. Chairman, Pres & CEO (Age 62)
  • Mr. Peter J. Kuipers, Exec. VP & CFO (Age 47)
  • Mr. Daniel S. Johnston, Exec. VP, Chief Legal & Admin. Officer and Corp. Sec. (Age 55)
  • Mr. Joseph Brian Spears, VP of Corp. Fin. & Chief Accounting Officer (Age 59)
  • Mr. Nhat H. Ngo, Exec. VP of Marketing, Strategy & Bus. Devel. (Age 46)

Who are Omnicell's major shareholders?

Omnicell's stock is owned by many different of institutional and retail investors. Top institutional investors include Conestoga Capital Advisors LLC (3.80%), State Street Corp (2.81%), Eagle Asset Management Inc. (2.02%), Carillon Tower Advisers Inc. (1.48%), Fisher Asset Management LLC (1.00%) and Voya Investment Management LLC (0.92%). Company insiders that own Omnicell stock include Dan S Johnston, Gary S Petersmeyer, James T Judson, Joanne B Bauer, Jorge R Taborga, Joseph Brian Spears, Nhat H Ngo, Peter J Kuipers, Randall A Lipps, Robin Gene Seim and Scott Peter Seidelmann. View Institutional Ownership Trends for Omnicell.

Which institutional investors are selling Omnicell stock?

OMCL stock was sold by a variety of institutional investors in the last quarter, including Pwmco LLC, Russell Investments Group Ltd., Man Group plc, Squarepoint Ops LLC, Stifel Financial Corp, Strs Ohio, Mackay Shields LLC and Convergence Investment Partners LLC. Company insiders that have sold Omnicell company stock in the last year include Dan S Johnston, Gary S Petersmeyer, Joanne B Bauer, Jorge R Taborga, Joseph Brian Spears, Nhat H Ngo, Peter J Kuipers, Randall A Lipps and Scott Peter Seidelmann. View Insider Buying and Selling for Omnicell.

Which institutional investors are buying Omnicell stock?

OMCL stock was bought by a variety of institutional investors in the last quarter, including Peregrine Capital Management LLC, SG Capital Management LLC, Point72 Asset Management L.P., Carillon Tower Advisers Inc., Voya Investment Management LLC, Millennium Management LLC, Rice Hall James & Associates LLC and Tygh Capital Management Inc.. View Insider Buying and Selling for Omnicell.

How do I buy shares of Omnicell?

Shares of OMCL can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

What is Omnicell's stock price today?

One share of OMCL stock can currently be purchased for approximately $81.52.

How big of a company is Omnicell?

Omnicell has a market capitalization of $3.42 billion and generates $787.31 million in revenue each year. The company earns $37.73 million in net income (profit) each year or $1.53 on an earnings per share basis. Omnicell employs 2,480 workers across the globe.View Additional Information About Omnicell.

What is Omnicell's official website?

The official website for Omnicell is http://www.omnicell.com/.

How can I contact Omnicell?

Omnicell's mailing address is 590 EAST MIDDLEFIELD ROAD, MOUNTAIN VIEW CA, 94043. The company can be reached via phone at 650-251-6100 or via email at [email protected]


MarketBeat Community Rating for Omnicell (NASDAQ OMCL)

Community Ranking:  2.8 out of 5 (star star)
Outperform Votes:  425 (Vote Outperform)
Underperform Votes:  325 (Vote Underperform)
Total Votes:  750
MarketBeat's community ratings are surveys of what our community members think about Omnicell and other stocks. Vote "Outperform" if you believe OMCL will outperform the S&P 500 over the long term. Vote "Underperform" if you believe OMCL will underperform the S&P 500 over the long term. You may vote once every thirty days.
This page was last updated on 12/8/2019 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.

Yahoo Gemini Pixel